Ethical dilemna, what to do?

You are a managing clinical research pharmacist employed by a large teaching hospital and university located in the Midwest. You work in a lab where the head researcher, Dr. blake, is world renowned for his expertise on cardiac drugs. For the last year, you have been working on a project collecting data on patients’ absorption and metabolism of two digoxin products in conjunction with a study grant from huey’s Bathtub Generics Company. This grant generates $1,000,000 per year for the hospital and University and entirely funds the salaries of yourself and three lab technicians in addition to all of the overhead costs ociated with the study. As the lab manager, you are handsomely compensated at the rate of $150,000 per year plus benefits and fringes. One of the fringes is stock options whereby you will be awarded stock in huey’s company worth over $500,000 if the study results meet the goals of the study. You get nothing and your job will be eliminated at the end of the study period